Pacira BioSciences
PCRX
PCRX
187 hedge funds and large institutions have $2.01B invested in Pacira BioSciences in 2018 Q3 according to their latest regulatory filings, with 46 funds opening new positions, 53 increasing their positions, 59 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
4% less call options, than puts
Call options by funds: $42.5M | Put options by funds: $44.4M
5.48% less ownership
Funds ownership: 105.3% → 99.83% (-5.5%)
10% less repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 59
Holders
187
Holding in Top 10
4
Calls
$42.5M
Puts
$44.4M
Top Buyers
| 1 | +$19.3M | |
| 2 | +$18.5M | |
| 3 | +$17.6M | |
| 4 |
PC
Polar Capital
London,
United Kingdom
|
+$13.9M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$12M |
Top Sellers
| 1 | -$67.2M | |
| 2 | -$51.5M | |
| 3 | -$44.7M | |
| 4 |
DCM
Daruma Capital Management
New York
|
-$33.1M |
| 5 |
ECP
Elk Creek Partners
Denver,
Colorado
|
-$31.6M |